STOCK TITAN

Adicet Bio to Participate in Stifel 2021 Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Adicet Bio, Inc. (Nasdaq: ACET) announced that CEO Chen Schor will present at the Stifel 2021 Virtual Healthcare Conference on November 15, 2021, at 4:00 pm ET. The event details, including access to a live audio webcast, are available on Adicet's investor website. The company is focused on developing innovative allogeneic gamma delta T cell therapies for cancer and other diseases, enhancing tumor targeting and immune response.

Positive
  • None.
Negative
  • None.

MENLO PARK, Calif., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering and developing first-in-class allogeneic gamma delta T cell therapies for cancer and other diseases, today announced that Chen Schor, President and Chief Executive Officer, will present at the Stifel 2021 Virtual Healthcare Conference taking place on November 15-17, 2021.

Details of the events are as follows:

Date:  Monday, November 15, 2021
Time:  4:00 pm ET

A live audio webcast of the of the Stifel presentation can be accessed on the Investors section of Adicet Bio’s website at https://investor.adicetbio.com. An archived replay will be available for 30 days following the presentation.

About Adicet Bio, Inc.
Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like targeting moieties to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. For more information, please visit our website at http://www.adicetbio.com.

Adicet Bio., Inc.
Investor and Media Contacts

Anne Bowdidge
abowdidge@adicetbio.com

Janhavi Mohite
Stern Investor Relations, Inc.
212-362-1200
janhavi.mohite@sternir.com


FAQ

When is Adicet Bio presenting at the Stifel 2021 Virtual Healthcare Conference?

Adicet Bio will present at the Stifel 2021 Virtual Healthcare Conference on November 15, 2021.

Who is the CEO of Adicet Bio presenting at the conference?

Chen Schor, the President and CEO, will be presenting at the conference.

What time will Adicet Bio's presentation start?

The presentation will start at 4:00 pm ET.

How can I access the live audio webcast of the Adicet Bio presentation?

The live audio webcast can be accessed on the Investors section of Adicet Bio’s website.

What technologies is Adicet Bio developing for cancer treatment?

Adicet Bio is developing first-in-class allogeneic gamma delta T cell therapies.

Adicet Bio, Inc.

NASDAQ:ACET

ACET Rankings

ACET Latest News

ACET Stock Data

80.65M
82.40M
1.59%
76.44%
4.16%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BOSTON